ARMATA PHARMACEUTICALS, INC. Adjustment of Warrants Granted for Services
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Adjustment of Warrants Granted for Services of $4.21 million for the 0-month period ending 2015-03-16, per its 10-Q filed 2015-05-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:AdjustmentOfWarrantsGrantedForServices · last filed 2015-05-15
- 2015-03-16: Adjustment of Warrants Granted for Services 0 month $4.21M.
| Period end | Adjustment of Warrants Granted for Services 0 month |
|---|---|
| 2015-03-16 | $4.21M 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |